Latest filing published 14 May 2020 for Ayala Pharmaceuticals, Inc., €691k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Harel Insurance Co Ltd: trading record in brief
Harel Insurance Co Ltd discloses dealings in Ayala Pharmaceuticals, Inc. to SEC (Form 4). We count 4 filings, every one of them for a trade on 12 May 2020.
No open-market sale appears; the market trades are 2 purchases worth €7.6M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 14 May 2020 came the latest disclosure, an open-market purchase for €691k in Ayala Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Harel Insurance Co Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$15.009.1% of flowCommon Stock, par value $0.01 per shareSEC:0001178913-20-001490:2Canonical exit: 10 Aug 2020 (T+90)
- 500,000 shares@ US$15.0090.9% of flowCommon Stock, par value $0.01 per shareSEC:0001178913-20-001490:3Canonical exit: 10 Aug 2020 (T+90)
- 307,692 sharesCommon Stock, par value $0.01 per shareSEC:0001178913-20-001490:0
- 211,757 sharesCommon Stock, par value $0.01 per shareSEC:0001178913-20-001490:1
4 of 4 declarations